Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Pool

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Plos One|August 6, 2014
"Let's talk about sex": a qualitative study of Rwandan adolescents' views on sex and HIVJennifer Ilo Van Nuil, Philippe Mutwa, Brenda Asiimwe-Kateera, et al.
Malaria Journal|August 12, 2009
Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settingsMarjolein Gysels, Christopher Pell, Don P Mathanga, et al.
Lancet (London, England)|September 21, 2010
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialSheena McCormack, Gita Ramjee, Anatoli Kamali, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Plos One|August 6, 2014
"Let's talk about sex": a qualitative study of Rwandan adolescents' views on sex and HIVJennifer Ilo Van Nuil, Philippe Mutwa, Brenda Asiimwe-Kateera, et al.
Malaria Journal|August 12, 2009
Community response to intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in five African settingsMarjolein Gysels, Christopher Pell, Don P Mathanga, et al.
Lancet (London, England)|September 21, 2010
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trialSheena McCormack, Gita Ramjee, Anatoli Kamali, et al.
Pageof 8